JP7763246B2 - カンナビノイドの調製方法 - Google Patents
カンナビノイドの調製方法Info
- Publication number
- JP7763246B2 JP7763246B2 JP2023514802A JP2023514802A JP7763246B2 JP 7763246 B2 JP7763246 B2 JP 7763246B2 JP 2023514802 A JP2023514802 A JP 2023514802A JP 2023514802 A JP2023514802 A JP 2023514802A JP 7763246 B2 JP7763246 B2 JP 7763246B2
- Authority
- JP
- Japan
- Prior art keywords
- cbd
- filter aid
- substep
- reaction mixture
- winterization
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/348—Cannabaceae
- A61K36/3482—Cannabis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/0203—Solvent extraction of solids with a supercritical fluid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/028—Flow sheets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
- B01D11/0288—Applications, solvents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/04—Solvent extraction of solutions which are liquid
- B01D11/0492—Applications, solvents used
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D9/0004—Crystallisation cooling by heat exchange
- B01D9/0013—Crystallisation cooling by heat exchange by indirect heat exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D9/0036—Crystallisation on to a bed of product crystals; Seeding
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D9/004—Fractional crystallisation; Fractionating or rectifying columns
- B01D9/0045—Washing of crystals, e.g. in wash columns
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Physics & Mathematics (AREA)
- Thermal Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2013765.9 | 2020-09-02 | ||
| GBGB2013765.9A GB202013765D0 (en) | 2020-09-02 | 2020-09-02 | Method of preparing cannabinoids |
| PCT/EP2021/073804 WO2022049007A1 (en) | 2020-09-02 | 2021-08-27 | Method of preparing cannabinoids |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023539898A JP2023539898A (ja) | 2023-09-20 |
| JP2023539898A5 JP2023539898A5 (cg-RX-API-DMAC10.html) | 2024-09-04 |
| JP7763246B2 true JP7763246B2 (ja) | 2025-10-31 |
Family
ID=72749568
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023514802A Active JP7763246B2 (ja) | 2020-09-02 | 2021-08-27 | カンナビノイドの調製方法 |
Country Status (12)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2531282A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabinoids in the treatment of epilepsy |
| GB2564383B (en) | 2017-06-23 | 2021-04-21 | Gw Res Ltd | Use of cannabidiol in the treatment of tumours assoicated with Tuberous Sclerosis Complex |
| GB2568929A (en) | 2017-12-01 | 2019-06-05 | Gw Res Ltd | Use of cannabinoids in the treatment of epilepsy |
| GB201916846D0 (en) | 2019-11-19 | 2020-01-01 | Gw Res Ltd | Cannabidiol-type cannabinoid compound |
| GB201916849D0 (en) | 2019-11-19 | 2020-01-01 | Gw Res Ltd | Cannabidiol-type cannabinoid compound |
| GB201916974D0 (en) | 2019-11-21 | 2020-01-08 | Gw Res Ltd | Cannabidol-type cannabinoid compound |
| GB202009321D0 (en) | 2020-06-18 | 2020-08-05 | Gw Res Ltd | Use of cannabinoids in the treatment of epilepsy |
| GB2597321A (en) | 2020-07-20 | 2022-01-26 | Gw Res Ltd | Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities |
| EP4006006A1 (en) * | 2020-11-27 | 2022-06-01 | Bridge Farm Nurseries Limited | Production of cannabidiol from hemp using subcritical liquid carbon dioxide |
| GB2602019A (en) | 2020-12-15 | 2022-06-22 | Gw Res Ltd | Cannabinoid derivative as a pharmaceutically active compound and method of preparation thereof |
| CA3264785A1 (en) | 2022-08-12 | 2024-02-15 | Jazz Pharmaceuticals Research Uk Limited | ORAL SOLID DOSAGE FORMS CONTAINING CANNABINOIDS |
| GB202416518D0 (en) | 2024-11-08 | 2024-12-25 | Jazz Pharmaceuticals Research Uk Ltd | Combination therapy |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010522741A (ja) | 2007-03-29 | 2010-07-08 | イッサム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム・リミテッド | 経鼻デリバリー用組成物 |
| JP2010538128A (ja) | 2007-08-31 | 2010-12-09 | マーテック バイオサイエンシーズ コーポレーション | 多価不飽和脂肪酸を含む固体脂肪組成物ならびにその使用および製造の方法 |
| JP2014530831A (ja) | 2011-10-20 | 2014-11-20 | エフ.ホフマン−ラ ロシュアーゲーF.Hoffmann−La Roche Aktiengesellschaft | イソオキサゾリル−メトキシ−ニコチン酸の調製方法 |
| JP2018521042A (ja) | 2015-06-17 | 2018-08-02 | ジーダブリュー リサーチ リミテッド | てんかんの治療におけるカンナビノイドの使用 |
| CN110304994A (zh) | 2019-07-01 | 2019-10-08 | 吴平 | 一种从工业大麻中提取高纯度大麻二酚的方法 |
| JP2020510068A (ja) | 2017-03-16 | 2020-04-02 | セラピュア バイオファーマ インコーポレーテッド | アルブミンの精製方法 |
| JP2020528066A (ja) | 2017-07-26 | 2020-09-17 | イナルコ エス.アール.エル. | 工業用大麻のタイプからのカンナビノイドの製造方法 |
Family Cites Families (83)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000078979A (ja) | 1998-09-04 | 2000-03-21 | Taisho Pharmaceut Co Ltd | テトラヒドロカンナビノール酸シンターゼ遺伝子 |
| JP2001029082A (ja) | 1999-07-22 | 2001-02-06 | Yukihiro Masayama | カンナビジオール酸シンターゼをコードするdna |
| DE10051427C1 (de) | 2000-10-17 | 2002-06-13 | Adam Mueller | Verfahren zur Herstellung eines Tetrahydrocannabinol- und Cannabidiol-haltigen Extraktes aus Cannabis-Pflanzenmaterial sowie Cannabis-Extrakte |
| DK1361864T3 (en) | 2001-02-14 | 2014-03-03 | Gw Pharma Ltd | FLYLDENDE SPRAY FORMULATIONS FOR buccal administration of cannabinoids |
| US10538373B2 (en) | 2002-08-14 | 2020-01-21 | Gw Pharma Limited | Pharmaceutical formulation |
| MXPA05001621A (es) | 2002-08-14 | 2005-08-19 | Gw Pharma Ltd | Extraccion de cannabinoides farmaceuticamente activos de materiales vegetales. |
| GB2393182B (en) | 2002-09-23 | 2007-03-14 | Gw Pharma Ltd | Method of preparing cannabidiol from plant material |
| CN101193884A (zh) | 2005-06-13 | 2008-06-04 | 惠氏公司 | 微管蛋白抑制剂和其制备方法 |
| MY148798A (en) * | 2005-11-08 | 2013-05-31 | Suntory Holdings Ltd | Method of refining episesamin |
| GB2456183A (en) | 2008-01-04 | 2009-07-08 | Gw Pharma Ltd | Anti-psychotic composition comprising cannabinoids and anti-psychotic medicament |
| GB2471987B (en) | 2008-06-04 | 2012-02-22 | Gw Pharma Ltd | Anti-tumoural effects of cannabinoid combinations |
| GB2475183B (en) | 2008-06-04 | 2011-11-23 | Gw Pharma Ltd | Cannabinoids in combination with non-cannabinoid chemotherapeutic agent that are selective estrogen receptor modulators |
| GB2478595B (en) | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
| TWI583374B (zh) | 2010-03-30 | 2017-05-21 | Gw伐瑪有限公司 | 使用植物大麻素次大麻二酚(cbdv)來治療癲癇之用途 |
| GB2487712B (en) | 2011-01-04 | 2015-10-28 | Otsuka Pharma Co Ltd | Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy |
| EP2500072A1 (en) * | 2011-03-15 | 2012-09-19 | LEK Pharmaceuticals d.d. | A novel process of residual solvent removal |
| CN102351628B (zh) * | 2011-08-10 | 2014-04-16 | 济南卡博唐生物科技有限公司 | 从异己烷和甲醇混合溶剂中除去甲醇的方法 |
| GB2495118B (en) | 2011-09-29 | 2016-05-18 | Otsuka Pharma Co Ltd | A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD) |
| GB2504263B (en) | 2012-06-08 | 2015-09-16 | Gw Pharma Ltd | Synergistic therapies for neuroprotection |
| CN102925295A (zh) * | 2012-10-30 | 2013-02-13 | 陕西启源科技发展有限责任公司 | 一种利用餐饮废油生产生物柴油的制备方法 |
| GB2515312A (en) | 2013-06-19 | 2014-12-24 | Gw Pharma Ltd | The use of phytocannabinoids in the treatment of ovarian carcinoma |
| GB2516814B (en) | 2013-06-19 | 2016-08-31 | Otsuka Pharma Co Ltd | Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer |
| GB2530001B (en) | 2014-06-17 | 2019-01-16 | Gw Pharma Ltd | Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy |
| GB2527591A (en) | 2014-06-27 | 2015-12-30 | Gw Pharma Ltd | 7-hydroxy cannabidiol (7-OH-CBD) for use in the treatment of non-alcoholic fatty liver disease (NAFLD) |
| GB2527599A (en) | 2014-06-27 | 2015-12-30 | Gw Pharma Ltd | Use of 7-OH-Cannabidiol (7-OH-CBD) and/or 7-OH-Cannabidivarin (7-OH-CBDV) in the treatment of epilepsy |
| GB2527590A (en) | 2014-06-27 | 2015-12-30 | Otsuka Pharma Co Ltd | Active pharmaceutical ingredient (API) comprising cannabinoids for use in the treatment of cancer |
| GB2531282A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabinoids in the treatment of epilepsy |
| GB2531281A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabidiol in the treatment of intractable epilepsy |
| GB2531283A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabidiols in the treatment of degenerative skeletal muscle diseases |
| GB2531278A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabidiol in the treatment of intractable epilepsy |
| GB2531280A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabidiol in the treatment of intractable epilepsy |
| US11034639B2 (en) * | 2015-01-22 | 2021-06-15 | Phytoplant Research S.L. | Methods of purifying cannabinoids using liquid:liquid chromatography |
| GB2541191A (en) | 2015-08-10 | 2017-02-15 | Gw Pharma Ltd | Use of cannabinoids in the treatment of epilepsy |
| GB2542155B (en) | 2015-09-09 | 2018-08-01 | Gw Pharma Ltd | Use of cannabidiol in the treatment of mental disorders |
| GB2542797A (en) | 2015-09-29 | 2017-04-05 | Gw Pharma Ltd | Use of cannabinoids in the treatment of inflammatory skin diseases |
| GB2548873B (en) | 2016-03-31 | 2020-12-02 | Gw Res Ltd | Use of Cannabidiol in the Treatment of SturgeWeber Syndrome |
| GB2551985B (en) | 2016-07-01 | 2019-01-30 | Gw Res Ltd | Novel formulation |
| GB2551986A (en) | 2016-07-01 | 2018-01-10 | Gw Res Ltd | Parenteral formulations |
| GB2551987A (en) | 2016-07-01 | 2018-01-10 | Gw Res Ltd | Oral cannabinoid formulations |
| GB2553139A (en) | 2016-08-25 | 2018-02-28 | Gw Res Ltd | Use of cannabinoids in the treatment of multiple myeloma |
| US10155176B1 (en) | 2016-11-03 | 2018-12-18 | Healer, LLC | Process for the production of a concentrated cannabinoid product |
| GB2557921A (en) | 2016-12-16 | 2018-07-04 | Gw Res Ltd | Use of cannabinoids in the treatment of angelman syndrome |
| GB2559774B (en) | 2017-02-17 | 2021-09-29 | Gw Res Ltd | Oral cannabinoid formulations |
| GB2560019A (en) | 2017-02-27 | 2018-08-29 | Gw Res Ltd | Use of cannabinoids in the treatment of leukaemia |
| CN107011125B (zh) * | 2017-05-06 | 2020-07-28 | 云南汉木森生物科技有限责任公司 | 一种富集大麻二酚的方法 |
| GB2564383B (en) | 2017-06-23 | 2021-04-21 | Gw Res Ltd | Use of cannabidiol in the treatment of tumours assoicated with Tuberous Sclerosis Complex |
| US9919241B1 (en) | 2017-06-27 | 2018-03-20 | Entheo Gardens Inc | Extraction method |
| US10189762B1 (en) | 2017-07-07 | 2019-01-29 | Orochem Technologies, Inc. | Process for purification and separation of cannabinoids, from dried hemp and cannabis leaves |
| GB201715919D0 (en) | 2017-09-29 | 2017-11-15 | Gw Res Ltd | use of cannabinoids in the treatment of epilepsy |
| GB2568471B (en) | 2017-11-15 | 2022-04-13 | Gw Res Ltd | Use of cannabinoids in the treatment of epilepsy |
| GB2568929A (en) | 2017-12-01 | 2019-06-05 | Gw Res Ltd | Use of cannabinoids in the treatment of epilepsy |
| GB2572125B (en) | 2018-01-03 | 2021-01-13 | Gw Res Ltd | Pharmaceutical |
| GB2572126B (en) | 2018-01-03 | 2021-01-13 | Gw Res Ltd | Pharmaceutical |
| GB2569961B (en) | 2018-01-03 | 2021-12-22 | Gw Res Ltd | Pharmaceutical |
| GB2572737A (en) | 2018-01-24 | 2019-10-16 | Gw Res Ltd | Use of cannabinoids in the treatment of epilepsy |
| WO2019195752A1 (en) * | 2018-04-05 | 2019-10-10 | Canopy Holdings, LLC | Hemp powder |
| GB201806953D0 (en) | 2018-04-27 | 2018-06-13 | Gw Res Ltd | Cannabidiol Preparations |
| WO2020028198A1 (en) * | 2018-08-03 | 2020-02-06 | Biomass Oil Separation Solutions, Llc | Processes and apparatus for extraction of substances and enriched extracts from plant material |
| GB2579179A (en) | 2018-11-21 | 2020-06-17 | Gw Res Ltd | Cannabidiol-type cannabinoid compound |
| CA3138732A1 (en) | 2018-11-30 | 2020-06-04 | Canopy Growth Corporation | Water-soluble formulations of cannabinoids or cannabis-derived compounds, methods of making and use |
| GB2580881A (en) | 2018-11-30 | 2020-08-05 | Gw Res Ltd | Use of cannabinoids in the treatment of epilepsy |
| US10413845B1 (en) * | 2018-12-14 | 2019-09-17 | Socati Technologies | Processes for solvent extraction of cannabinoids, terpenes and flavonoids from biomass |
| US10414709B1 (en) * | 2018-12-14 | 2019-09-17 | Socati Technologies | Processes for solvent extraction of cannabinoids, terpenes and flavonoids from biomass |
| GB2580653A (en) | 2019-01-21 | 2020-07-29 | Gw Res Ltd | Use of cannabinoids in the treatment of comorbidities associated with epilepsy |
| GB2581517A (en) | 2019-02-22 | 2020-08-26 | Gw Res Ltd | Use of cannabinoids in the treatment of epilepsy |
| GB2581987B (en) | 2019-03-06 | 2021-11-17 | Gw Res Ltd | Use of cannabidiol in combination with antibiotics |
| GB2584140A (en) | 2019-05-23 | 2020-11-25 | Gw Res Ltd | Use of cannabidiol in the treatment of epileptic spasms |
| GB2584341B (en) | 2019-05-31 | 2023-03-01 | Gw Res Ltd | Cannabinoid formulations |
| GB201910389D0 (en) | 2019-07-19 | 2019-09-04 | Gw Pharma Ltd | Novel compounds, methods for their manufacture, and uses thereof |
| GB2586026A (en) | 2019-07-29 | 2021-02-03 | Gw Res Ltd | Use of cannabidol in the treatment of Dravet syndrome |
| GB2588576A (en) | 2019-08-27 | 2021-05-05 | Gw Res Ltd | Use of cannabinoids in the treatment of dyskinesia associated with Parkinson's disease |
| GB2588461A (en) | 2019-10-25 | 2021-04-28 | Gw Res Ltd | Use of cannabidiol preparations in the treatment of absence epilepsy |
| GB2588457B (en) | 2019-10-25 | 2022-12-21 | Gw Res Ltd | Cannabinoid compound |
| GB201916846D0 (en) | 2019-11-19 | 2020-01-01 | Gw Res Ltd | Cannabidiol-type cannabinoid compound |
| GB201916849D0 (en) | 2019-11-19 | 2020-01-01 | Gw Res Ltd | Cannabidiol-type cannabinoid compound |
| GB201916974D0 (en) | 2019-11-21 | 2020-01-08 | Gw Res Ltd | Cannabidol-type cannabinoid compound |
| GB201916977D0 (en) | 2019-11-21 | 2020-01-08 | Gw Res Ltd | Cannibidol-type cannabinoid compound |
| GB201918846D0 (en) | 2019-12-19 | 2020-02-05 | Gw Res Ltd | Oral cannabinoid formulations |
| GB202002754D0 (en) | 2020-02-27 | 2020-04-15 | Gw Res Ltd | Methods of treating tuberous sclerosis complex with cannabidiol and everolimus |
| US20210370198A1 (en) * | 2020-05-29 | 2021-12-02 | Chemtor, Lp | Purification and extraction of cannabinoids |
| US20220087951A1 (en) | 2020-09-18 | 2022-03-24 | GW Research Limited | Use of cannabinoids in the treatment of epilepsy |
| US11160757B1 (en) | 2020-10-12 | 2021-11-02 | GW Research Limited | pH dependent release coated microparticle cannabinoid formulations |
| US11815187B2 (en) | 2022-01-26 | 2023-11-14 | Maag Germany Gmbh | 3-port valve |
-
2020
- 2020-09-02 GB GBGB2013765.9A patent/GB202013765D0/en not_active Ceased
-
2021
- 2021-08-27 CA CA3190849A patent/CA3190849A1/en active Pending
- 2021-08-27 KR KR1020237011264A patent/KR20230061484A/ko active Pending
- 2021-08-27 WO PCT/EP2021/073804 patent/WO2022049007A1/en not_active Ceased
- 2021-08-27 JP JP2023514802A patent/JP7763246B2/ja active Active
- 2021-08-27 CN CN202180054371.6A patent/CN116056773B/zh active Active
- 2021-08-27 AU AU2021338469A patent/AU2021338469A1/en active Pending
- 2021-08-27 US US18/043,810 patent/US12539472B2/en active Active
- 2021-08-27 EP EP21772706.4A patent/EP4208273A1/en active Pending
- 2021-08-27 MX MX2023002535A patent/MX2023002535A/es unknown
- 2021-08-31 GB GB2112397.1A patent/GB2600528A/en not_active Withdrawn
- 2021-09-01 TW TW110132437A patent/TW202222299A/zh unknown
- 2021-09-02 PY PY202102175980A patent/PY2175980A/es unknown
-
2025
- 2025-12-24 US US19/432,540 patent/US20260166448A1/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010522741A (ja) | 2007-03-29 | 2010-07-08 | イッサム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム・リミテッド | 経鼻デリバリー用組成物 |
| JP2010538128A (ja) | 2007-08-31 | 2010-12-09 | マーテック バイオサイエンシーズ コーポレーション | 多価不飽和脂肪酸を含む固体脂肪組成物ならびにその使用および製造の方法 |
| JP2014530831A (ja) | 2011-10-20 | 2014-11-20 | エフ.ホフマン−ラ ロシュアーゲーF.Hoffmann−La Roche Aktiengesellschaft | イソオキサゾリル−メトキシ−ニコチン酸の調製方法 |
| JP2018521042A (ja) | 2015-06-17 | 2018-08-02 | ジーダブリュー リサーチ リミテッド | てんかんの治療におけるカンナビノイドの使用 |
| JP2020510068A (ja) | 2017-03-16 | 2020-04-02 | セラピュア バイオファーマ インコーポレーテッド | アルブミンの精製方法 |
| JP2020528066A (ja) | 2017-07-26 | 2020-09-17 | イナルコ エス.アール.エル. | 工業用大麻のタイプからのカンナビノイドの製造方法 |
| CN110304994A (zh) | 2019-07-01 | 2019-10-08 | 吴平 | 一种从工业大麻中提取高纯度大麻二酚的方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| TW202222299A (zh) | 2022-06-16 |
| US20240293762A1 (en) | 2024-09-05 |
| US20260166448A1 (en) | 2026-06-18 |
| MX2023002535A (es) | 2023-03-14 |
| EP4208273A1 (en) | 2023-07-12 |
| AU2021338469A1 (en) | 2023-03-23 |
| GB202013765D0 (en) | 2020-10-14 |
| KR20230061484A (ko) | 2023-05-08 |
| GB2600528A (en) | 2022-05-04 |
| CN116056773B (zh) | 2026-07-24 |
| JP2023539898A (ja) | 2023-09-20 |
| CA3190849A1 (en) | 2022-03-10 |
| WO2022049007A1 (en) | 2022-03-10 |
| GB202112397D0 (en) | 2021-10-13 |
| US12539472B2 (en) | 2026-02-03 |
| PY2175980A (es) | 2022-04-18 |
| CN116056773A (zh) | 2023-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023539898A (ja) | カンナビノイドの調製方法 | |
| EP3274321B1 (en) | Cannabidiol isolate from industrial-hemp and use thereof in pharmaceutical and/or cosmetic preparations | |
| CA3027108C (en) | Purification and separation techniques for cannabinoids | |
| EP1536810B1 (en) | Extraction of pharmaceutically active cannabinoids from plant materials | |
| TW202027835A (zh) | 使用層析性樹脂分離組份/大麻鹼之方法 | |
| JP7408045B2 (ja) | 非向精神性カンナビノイドを含有する包接物及びその調製方法 | |
| WO2020117688A3 (en) | Process for purifying tetrahydrocannabinol using a chromatographic stationary phase | |
| WO2019152736A9 (en) | Hemp powder | |
| EP2407153B1 (en) | Preparation method of carotenoid oil suspensions with low viscosity and high fluidity | |
| JPH07506837A (ja) | 高シス−β−カロチン組成物 | |
| CN111117773B (zh) | 一种从蒜头果油中分离神经酸的方法及应用 | |
| CN114502147A (zh) | 包含黄体素和玉米黄质的具有增强的生物利用度的叶黄素组合物 | |
| Xu et al. | Safety evaluation of meso-zeaxanthin | |
| CN111808670A (zh) | 一种从大麻中提取纯化广谱大麻油的方法 | |
| Chen et al. | Lutein attenuated methylglyoxal‐induced oxidative damage and apoptosis in PC12 cells via the PI3K/Akt signaling pathway | |
| JP2026501968A (ja) | カンナビノイド組成物、ならびに神経変性疾患または障害及びがんの治療におけるその使用 | |
| CN114685268B (zh) | 一种大麻二酚酸的提取方法及纯化方法 | |
| US20250213596A1 (en) | Cannabinoid-containing compositions | |
| CA3233039A1 (en) | Full spectrum hemp oil compositions field | |
| KR20260044829A (ko) | 대마 초임계 추출물을 포함하는 신경세포 보호용 조성물 | |
| WO2023175496A1 (en) | Cannabinoid-containing compositions | |
| Boumghar | Development of bioactive cannabis extracts through optimization of green supercritical fluid process | |
| Shen et al. | 138616Effect of Solvent Recrystallization on the Purification of Crude Phytosterols Derived from Corn Oil Deodorizer Distillate | |
| AU664104B2 (en) | High CIS beta-carotene composition | |
| Kasi | The anti-amyloidogenic effect of natural product extracts on amyloid-like fibril formation of trypsin in aqueous organic solvents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240827 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240827 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250520 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20250521 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250820 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20250821 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20250924 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20251021 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7763246 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |